
20n YC 申请
20n 在 Winter 2015 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2015
- 行业
- HealthcareIndustrial Bio
- 团队规模
- 2
- 状态
- Inactive
- 已发布
- 2014
创始人
Saurabh SrivastavaFounder/CEO
Chris AndersonFounder/CSO
20n 做什么
The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing and synthesis being mainstream now [1], 20n provides the computational systems that predict DNA design for novel industrial biotech and health applications. At 20n, we are taking a fresh look at turning biological data into information. We approach it as a big data learning problem, and bring to bear techniques from machine learning, distributed systems, AI planning, program synthesis, data mining, and natural language processing. With the support of DARPA [2], we are building a team of computer scientists, and bioengineers to look at biology in fundamentally new ways. Our current customers include industrial biotech firms that are leading the charge in transitioning us from traditional unsustainable means of manufacturing to sustainable biological processes leading to advanced fuels, materials, therapeutics, and flavors and fragrances. 20n’s technology helps them enter markets previously thought inaccessible for biology. [1] Sequencing DNA costs $4k/genome ( and is expected to go down to $1k/genome. Synthesizing DNA is at 20cents/bp, and is expected to go down to 0.1cents/bp. [2] DARPA in the past supported work that led to the internet, stealth planes, GPS, and even Douglas Engelbart’s mother-of-all-demos.
20n 的 YC 申请,重建版
Y Combinator 申请
20n,Winter 2015 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
20n
Using AI to predict biochemistry for manufacturing
We are building computational systems that use AI and machine learning to predict DNA designs for industrial biotech and therapeutics. Our product helps industrial biotech firms design biological systems that can produce fuels, materials, flavors, and medicines that were previously inaccessible by traditional methods.
We live in San Francisco, CA, and would base the company here after YC.
San Francisco has the technical talent and biotech ecosystem we need to grow. It keeps us close to early industrial biotech customers and partners.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 20n 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 20n 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 20n 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
20n 是哪个 YC 批次的?
20n 是 Y Combinator Winter 2015 批次的成员。
谁创立了 20n?
20n 由 Saurabh Srivastava, Chris Anderson 创立。
20n 做什么?
Using AI to predict biochemistry for manufacturing and therapeutics
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 20n 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。